Skip to content
Sign in
Artwork for Drug Diaries
Health & FitnessMedicineScienceLife SciencesTechnology

Drug Diaries

Kaushik Trivedi

Welcome to "Drug Diaries," the podcast exploring pharmaceuticals, life sciences, and biotechnology. Host Kaushik Trivedi, with over two decades of industry experience, shares his expertise. Kaushik has worked with IQVIA, Cognizant, Wipro, and more, and holds degrees in pharmaceutical chemistry, marketing, and advertising. Kaushik's expertise spans: - Data-Driven GTM & Customer Engagement - CRM, Marketing Cloud, SFE, & Commercial Analytics - AI/ML/NLP in Life Sciences - Population Health Management - IoT & Connected Devices - Content Production & MLR Approval - R&D, Clinical, Pharmacovigilance, Medical, & Regulatory - Business Transformation "Drug Diaries" covers research, drug discovery, AI in health, GTM strategies, customer engagement, analytics, patient safety, product engineering, and more. Join Kaushik for insights and discussions on the ever-evolving pharma and biotech landscape. Each episode is a deep dive into the industry's heart. Welcome to "Drug Diaries."

Play
Open in
  • 22 episodes
  • Avg 1 hr 9 min
  • English

Episodes 22

NewestOldestLongest
All20Unplayed20In progress0Played0
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • S1 · E81
    October 12 · 49 min· Video

    He Left Big Pharma To Solve Cancer's Biggest Secret: Liquid Biopsies vs Traditional Testing

    Liquid biopsies could change how we detect cancer, but what happens when you are caught in the waiting period for a diagnosis? Jeff Bousfield shares his personal account of finding a concerning symptom and the subsequent wait for a cystoscopy. This period of medical uncertainty highlights the intense emotional toll patients experience while navigating the system. Beyond the personal story, we look at the role of the NHS in managing these diagnostic pathways. We examine how new testing methods like liquid biopsies aim to reduce the anxiety caused by long waits and provide faster answers for those facing a potential cancer diagnosis. Subscribe for weekly healthcare infrastructure breakdowns, and let me know in the comments how you think diagnostic wait times could be improved. Chapters 00:00 Introduction to Nonicus and cancer diagnostics 03:28 The patient experience: Waiting and anxiety 08:03 Leadership lessons from scaling startups to pharma 16:01 Reflections on career and future aspirations 18:40 Psychological impact of invasive procedures 22:23 The role of cystoscopy and how Galeas complements it 24:25 The patient pathway: From GP to diagnosis 26:09 Speeding up diagnosis: From sample to report 28:20 Decentralized testing and NHS integration 29:31 Explaining Galeas to a 12-year-old 33:11 Detecting recurrence and early relapse 34:58 Clinical trials and data endpoints 36:54 Test accuracy and predictive values 39:23 False positives and improving confidence 40:21 Analogy of airport security screening 41:07 Operational challenges in scaling up 44:23 Experience from COVID testing scale-up 47:37 The Birmingham ecosystem and Life Sciences Week 48:21 Core message for the upcoming event 49:21 Closing remarks and future outlook Get vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

  • S1 · E82
    October 12 · 1 hr 7 min· Video

    Why the UK is the World’s Best Kept Secret in Medicine

    Why is the UK a global leader in scientific discovery? Prof Chris Molloy joins us to discuss the future of UK life sciences. The UK has long been at the forefront of global invention, anchored by a unique network of world-leading universities and brilliant research talent. This conversation examines the foundations of that success and why the current environment remains so fertile for groundbreaking scientific discovery. We also look at the entrepreneurs converting these academic breakthroughs into tangible solutions. It is about more than just research; it is about building sustainable biotech startups capable of delivering real-world medical innovation that has the potential to save millions of lives. Subscribe for weekly insights on the business of healthcare, and let me know in the comments if you believe the UK can maintain its competitive edge in research. Chapters 00:00 The threat and opportunity in UK science 00:27 Why innovation needs to stay in the UK 01:24 What kind of life sciences nation does the UK want to be? 02:22 Professor Chris Molloy’s career journey 03:17 From pharma to biotech and informatics 05:04 Building the Medicines Discovery Catapult 09:04 The role of the Bioindustry Association 11:25 Carrying science into leadership 13:29 Misunderstandings about UK life sciences 17:09 UK’s long-term inventiveness and ambition 19:38 The UK’s biotech superpower 22:56 UK as a global biotech hub 24:05 Why successful companies often leave the UK 28:12 Bridging science and business 32:48 What government can do for biotech 34:37 Impact of biotech on patients and society 37:46 Speeding up medicine development 40:08 Why biotech should be regionalized 45:16 Birmingham’s unique biotech opportunities 47:58 What a thriving biotech ecosystem looks like 52:24 Connecting regional clusters for growth 54:14 Vision for UK biotech in 2036 57:14 Challenges and concerns for UK biotech 01:00:13 The importance of confidence and purpose 01:04:02 The collective responsibility for biotech success 01:04:44 Final thoughts and future outlook Get vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

  • S1 · E80
    September 23 · 1 hr 5 min· Video

    Why Your Immune System Fails After Cancer

    As we get older, our immune memory wanes, leaving us vulnerable to infections. Learn why this happens and what to watch for. Just as we experience cognitive changes with age, our aging immune system becomes less efficient at recognising pathogens. This natural decline means the body is slower to respond to threats, which significantly increases the risk of serious illness. We look at the biological reality of this process and why it makes older adults more susceptible to common infections. Exclusive Access: Life Sciences Week 2026 (#LSW26)!We are thrilled to announce that Drug Diaries is partnering with Life Sciences Week 2026 (21–25 September 2026), the UK’s premier gathering for biotech, pharma, med-tech, AI, and healthcare policy leaders! Join 3,000+ industry pioneers, policymakers, and investors as we dive deep into the future of healthcare innovation. Seats are filling fast—secure your spot today with our exclusive community discount! 🎟️ Register Now: https://lifesciencesweek.co.uk/attend/ ⚡ Exclusive Discount Code: DRUGDIARIES10 (Use at checkout for an exclusive discount!)Don't wait—claim your ticket now and be part of the national conversation shaping life sciences! Subscribe for weekly health insights, and let me know in the comments if you have questions about immune health. 0:00 The Hidden Toll of Modern Survival 0:45 Meet the Professor Behind the Lab Bench 7:20 From Medical Student to Immunology Expert 11:52 Why Survival Is No Longer Sufficient 18:17 Demystifying Secondary Immune Deficiency 31:24 The Long Road to Patient Recovery 38:30 The Unsung Hero of Modern Healthcare 52:45 The Power of Public-Private Partnerships 1:14:04 A Vision for the Future of Healthcare

  • S1 · E79
    August 29 · 50 min· Video

    Why 90% Of Cancer Treatments Fail – Are We Looking In The Wrong Place?

    In this conversation, Kaushik Trivedi interviews Professor Andrew Beggs, a pioneering figure in cancer genetics and surgery. They discuss the traditional approaches to cancer treatment and how Andrew's dual role as a surgeon and scientist allows him to bridge the gap between immediate patient care and long-term research. Andrew shares his personal journey, including moments of self-doubt, the emotional challenges of balancing surgery and research, and the sacrifices made in pursuit of excellence. The conversation also touches on the evolution of cancer understanding, the importance of collaboration in research, and the future of cancer treatment through genomics and immunotherapy. In this conversation, Andrew Beggs discusses the transformative potential of liquid biopsies, advancements in precision therapy, and the future of organoid technology in cancer treatment. He highlights the challenges in organoid culture and the revolutionary impact of long-read genomic sequencing. The discussion also covers the role of AI in cancer diagnostics, the emerging innovation hub in the West Midlands, and the barriers to biotech advancement in the UK. Finally, they touch on the significance of Life Sciences Week as a platform for fostering collaboration and innovation in the healthcare sector. Exclusive Access: Life Sciences Week 2026 (#LSW26)!We are thrilled to announce that Drug Diaries is partnering with Life Sciences Week 2026 (21–25 September 2026), the UK’s premier gathering for biotech, pharma, med-tech, AI, and healthcare policy leaders! Join 3,000+ industry pioneers, policymakers, and investors as we dive deep into the future of healthcare innovation. Seats are filling fast—secure your spot today with our exclusive community discount! 🎟️ Register Now: https://lifesciencesweek.co.uk/attend/ ⚡ Exclusive Discount Code: DRUGDIARIES10 (Use at checkout for an exclusive discount!)Don't wait—claim your ticket now and be part of the national conversation shaping life sciences! Chapters 00:00 Introduction to Andrew Beggs and his dual role in surgery and science 02:44 Andrew's motivation for combining surgery with genomics research 04:23 Early influences and the evolution of Andrew’s career 06:31 Overcoming self-doubt and career setbacks 09:48 Spark for cancer genetics and core beliefs changed 12:24 Handling emotional challenges of patient outcomes 14:29 Balancing clinical intensity with scientific research 16:01 Personal sacrifices and leadership in high-stakes environments 17:17 Lessons on leading multidisciplinary teams 21:19 Explaining cancer heterogeneity to a child 22:38 Progress in cancer genomics and immunotherapy 24:06 Liquid biopsy and its revolutionary potential 27:25 Organoids and personalized drug testing 34:48 Advances in long-read sequencing technology 37:50 AI in cancer diagnostics and research 40:48 Predicting immune responses with AI and genomics 42:22 West Midlands as a biotech innovation hub 47:43 Future of cancer treatment and diagnostic breakthroughs in 10 years Get vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

  • S1 · E78
    August 20 · 1 hr 12 min· Video

    The Man Who Saved the $50 Billion Drug (Against His Bosses)

    How one pharmaceutical development project generated 50 billion dollars despite management trying to kill it. See the high-stakes reality. In this episode, Dr. David Brown shares his 52-year journey in drug discovery, the transformative potential of AI in medicine, and the urgent need for the pharmaceutical industry to embrace paradigm shifts to reduce human suffering. You will hear the inside perspective of a clinical development committee meeting where the project was faced with a three-month deadline to prove efficacy or face total termination. This is for anyone interested in the friction between medical research and corporate budget constraints. Learn how drug discovery survives when budgets are cut to zero and leadership demands immediate results. We examine the tension of professional life when your career hinges on proving the viability of a vital medical treatment. Understand the pressure of navigating complex clinical trials while your own company actively attempts to shut you down. Subscribe for weekly career breakdowns and tell me, have you ever had to fight for a project you believed in against all odds? Chapters 0:00 The $50 Billion Discovery That Almost Never Was 5:05 From Punch Cards to AI-Driven Medicine 9:10 Why AI Must Be the Foundation, Not a Bolt-On 14:07 The Stagnation of Big Pharma's Financial Engine 18:06 The 90-Day Thread: A Project Hanging by a Wire 25:03 The Lightbulb Moment: Connecting the Dots 35:55 Navigating Power Plays in Legacy Organizations 42:21 Mapping Mountains and Valleys with AI Get vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

  • S1 · E77
    August 4 · 1 hr 17 min· Video

    Is West Midlands the next pharma innovation powerhub?

    In this episode, Kaushik Trivedi interviews Professor Neil Hanley about the transformative healthcare innovations happening in the West Midlands, UK. They explore regional collaboration, cutting-edge research, and the future of data-driven medicine. As a thank you to the Drug Diaries Podcast community, I am pleased to share an exclusive 10% discount for Life Sciences Week 2026. Use code: DRUGDIARIES10 https://lifesciencesweek.co.uk/conference-launch-tickets/ Chapters 00:00 Introduction to the West Midlands healthcare revolution 01:19 Neil Hanley's role in shaping UK health innovation 03:10 Neil Hanley's early career and scientific inspiration 11:13 The concept of the golden parallelogram in UK science 14:41 The strategic importance of Birmingham's diverse healthcare ecosystem 20:58 The Birmingham Health Innovation Campus and its facilities 25:31 Co-locating startups, scientists, and healthcare providers 32:44 Data-driven healthcare and AI in preventative medicine 38:44 Future directions in aging, longevity, and gene therapy 48:53 Neil Hanley's legacy and vision for Birmingham Get vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

  • S1 · E76
    July 29 · 1 hr 8 min· Video

    AI in Pharma: Why The Hype Doesn't Match Reality

    This discussion breaks down the current state of artificial intelligence integration within the pharmaceutical sector. We examine why scaling AI solutions is a major hurdle for many organisations and how to overcome the gap between technical capability and actual deployment. This is essential viewing for anyone trying to navigate the complexities of adopting advanced technologies in a highly regulated environment. If you are a vendor selling to pharma, the advice provided here is critical. We discuss why generic pitches fail and why presenting concrete AI business cases is the only way to secure buy-in from stakeholders. Instead of focusing on hype, learn how to demonstrate measurable ROI and operational efficiency to decision-makers who need to see real-world results before committing to new partnerships. Subscribe for weekly B2B strategy breakdowns, and comment below on which industry sector you want us to analyse next. Chapters 00:00 Introduction to AI's role in healthcare decision-making 02:28 Flora Eduard's background and industry transformation 06:40 The surprising lack of data use in pharma decision-making 08:11 Leadership principles Flora refuses to compromise 12:45 Cultural insights from working across countries 16:08 Biggest setbacks and lessons learned 22:39 Digital transformation vs. digitization 28:41 Current state of AI experimentation in pharma 31:52 Understanding agentic AI and its differences from traditional AI 34:45 The future of AI and how soon it will arrive 40:49 AI's potential to improve patient outcomes 45:33 Skills needed for future leaders in the AI era 01:10:10 The future of pharma in 2035 01:11:48 Rapid fire insights and predictions Get vidIQ to grow your channel faster! 🚀https://vidiq.com/DrugDiaries Learn how to approach AI in pharma by focusing on proven business cases rather than theoretical potential. Discover what works today.

  • S1 · E75
    July 11 · 1 hr 1 min· Video

    The Content Disconnect That's Killing Healthcare

    Stop sending mass emails that land you on a blacklist. Learn why mass email practices hurt healthcare communication and how Maya offers a better way. Sending unsolicited bulk emails to entire departments is a fast way to get your domain blocked. This video explains the mechanics behind vendor blacklisting and why standard mass outreach strategies often fail in clinical environments. If you are struggling with low engagement or deliverability issues, understanding these risks is the first step toward fixing your outreach. We discuss the concept of Maya as a potential path forward. The core takeaway is that even the most advanced technical solutions fail if they do not fit the specific communication landscape of healthcare. We analyze why context and recipient relevance matter more than volume when you are trying to reach busy medical professionals. Subscribe for weekly email deliverability breakdowns, and comment below if you have ever faced a domain blacklist issue. keywords healthcare innovation, pharma digital transformation, content experience, AI in pharma, networking, pilot projects, healthcare technology key topics The importance of authentic human connection in healthcare Challenges and opportunities in pharma digital transformation The future of AI and agentic technology in healthcare Effective networking and relationship building in pharma Scaling pilots and proof of concepts for long-term success guest name: Gaurav Sanganee Chapters 00:00 The Crisis in Healthcare Communication 02:59 Breaking Away from Convention 05:25 The Role of Closing Delta and Relato 08:12 Navigating the Challenges of Pilots and Proof of Concepts 10:46 The Importance of Incremental Change 13:09 The Static Content Crisis in Pharma 15:41 The Future of Healthcare Communication 31:06 The Evolution of Content Delivery 35:44 Transforming Scientific Content Presentation 41:02 Embracing New Technologies in Pharma 47:30 The Future of Healthcare Tech 52:46 Rapid Fire Insights and Reflections Resources Founder - The MacDonald Story - https://www.imdb.com/title/tt0107048/ Maverick - https://www.imdb.com/title/tt1631867/ Relayto Content Experience Platform - https://relayto.com/ Closing Delta - https://www.linkedin.com/company/closing-delta/about/ Guest links LinkedIn: https://www.linkedin.com/in/gaurav-sanganee/ Get vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

  • S1 · E74
    July 2 · 1 hr 19 min· Video

    The Market Access Secret Nobody's Talking About | Drug Pricing Exposed

    In this conversation, Kaushik Trivedi speaks with Jennifer Kane Burk Mosa, who has navigated a diverse career as a diplomat, healthcare executive, entrepreneur, and comedian. They explore the themes of curiosity, impact, and the importance of understanding human behavior in various sectors, particularly healthcare. Jennifer emphasizes the need for collaboration and listening to patients to create meaningful solutions in healthcare systems. The discussion also touches on the challenges of transitioning from public to private healthcare and the complexities of global health initiatives. In this conversation, Jennifer Cain Birkose discusses the importance of understanding patient interactions with technology and the role of ethnography in pharmaceutical development. She highlights the mission of Viva Valley in supporting older adults to live independently and delves into the implications of the MFN policy on drug pricing and access. Additionally, she explains the critical role of market access professionals in navigating the complexities of the pharmaceutical industry and provides insights into a typical day in their lives. In this conversation, Jennifer Cain Birkose and Kaushik Trivedi explore the critical role of patient involvement in healthcare, the definition of independence for older adults, and the importance of quality of life over mere longevity. They discuss the lessons learned from older generations, the surprising journey into comedy, and how improv can serve as a valuable tool for leadership. The conversation also touches on the connection between laughter and trust, the embrace of nonlinear career paths, and the transformative power of the phrase 'Yes, And' in both personal and professional contexts. Chapters 00:00 The Courage to Become Many Things 02:16 Curiosity and Impact: A Life of Many Roles 06:50 The Thread of Impact in Healthcare and Beyond 11:27 Diplomacy and Human Behavior: Understanding Incentives 13:53 Transitioning from Public to Private Healthcare 20:50 Global Health Initiatives: Collaboration is Key 24:24 Listening to Patients: The Missing Voice in Healthcare 27:36 Understanding Patient Interactions with Technology 30:30 The Role of Ethnography in Pharma Development 31:45 Viva Valley: Supporting Independent Living for Older Adults 33:14 Exploring the MFN Policy and Its Implications 45:04 The Role of Market Access Professionals in Pharma 55:35 A Day in the Life of a Market Access Professional 57:53 The Importance of Patient Involvement 01:01:14 Defining Independence for Older Adults 01:04:30 Quality of Life vs. Length of Life 01:08:31 Lessons from Older Generations 01:10:23 The Surprising Journey into Comedy 01:13:10 Improv as a Leadership Tool 01:17:27 The Connection Between Laughter and Trust 01:22:04 Embracing Nonlinear Career Paths 01:23:58 The Power of 'Yes, And' Guest LinkedIn: https://protect.checkpoint.com/v2/r01/___https://www.linkedin.com/in/jennifer-cain-birkmose-ab05a6?utm_source=share_via&utm_content=profile&utm_medium=member_ios___.YzJ1OmFlc2FyYTE6YzpvOjQ2ZWVmZGEzMDY0YTU1OTlkYTFkZjVjM2YyMzQ5NWZjOjc6YzBmNDpiYjVhZjU0NGIxZTRkYThmMTkxYzU2NWYyNmZiMGM4YjQzMDAzNTU1YjNkZTFiOTFhZjY1MTJkNDQ5ZjIwYWFkOmg6VDpG Aesara: www.aesara.com MMV: https://www.mmv.org/ Vivavalet: www.vivavalet.com Ted talks https://www.ted.com/search?q=jennifer%20cain%20birkmose INC article reference: https://www.inc.com/suzanne-lucas/look-for-these-5-traits-to-find-your-high-potential-employees/91198182

  • S1 · E73
    July 2 · 1 hr 39 min· Video

    Your Skin Doesn't Care How Much Water You Drink

    Explore the fascinating science of skin biology with Benjamin Fuchs, a skincare expert with over 45 years of experience. Discover how internal health, nutrition, and cellular processes influence skin aging, acne, and overall skin health. In this episode, Benjamin Fuchs discusses the science behind skin health, debunks common skincare myths, and shares practical advice on how to support skin from the inside out. Discover how internal nutrition, proper skincare ingredients, and understanding skin signals can transform your approach to skin health. keywords skin biology, skincare science, collagen, hydration, aging, cellular health, skin care tips, Benjamin Fuchs skin health, skincare myths, internal nutrition, acne treatment, skincare ingredients, dermatology, skin aging, topical nutrients, skincare tips, health and wellness takeaways Skin is a living, breathing biochemical organ, not just a surface. Supporting internal health and blood circulation is key to skin health. Most skincare products disrupt the skin's electrical and biological processes. Exfoliation and supporting natural cell turnover strengthen skin. Structured water and supporting collagen production are vital for hydration. guest name Benjamin Fuchs Chapters 00:00 Understanding Skin: The Overlooked Organ 02:56 The Science of Skin: Beyond Surface Level 05:58 The Bioelectrical Nature of Skin 08:48 Skin Structure: Layers and Functions 12:04 The Journey of Skin Cells 14:53 Hydration vs. Moisturization: The Real Difference 18:02 The Role of Blood in Skin Health 20:57 Topical Solutions: What Really Works? 24:11 Exfoliation: The Key to Healthy Skin 34:59 The Science of Exfoliation 38:20 Understanding Structured Water 43:58 The Role of Collagen in Aging 48:44 Factors Contributing to Collagen Decline 52:59 Why Does Skin Age? 55:25 The Impact of Skin Tone on Aging 56:42 Acne: Understanding True vs Faux 01:08:05 Skincare Strategies for Teenagers 01:13:34 The Dangers of Benzoyl Peroxide 01:16:05 The Superiority of Salicylic Acid 01:18:38 The Importance of Active Ingredients 01:20:50 Nutritional Foundations for Skin Health 01:24:41 Understanding Skincare Labels 01:25:35 Key Principles for Skin Health 01:26:14 Rapid Fire Myths and Facts 01:31:17 Debunking Skincare Trends 01:35:59 The Truth About Moisturizers 01:37:27 Final Thoughts on Skin Health Resources Benjamin Fuchs' Website Vitamin A Supplements Zinc for Skin Health Selenium Supplements Salicylic Acid Topical Treatments Chemical Sunscreens and Alternatives Topical Nutrients for Skin

  • S1 · E72
    June 11 · 1 hr 32 min· Video

    Liz Parrish Modified Her Own DNA Here's What Happened

    Liz Parrish shares her groundbreaking journey into gene therapy, her motivations driven by her son's diagnosis, and her vision for a future where aging and disease are conquerable. This conversation explores the science, ethics, and future of longevity research, emphasizing the importance of innovation and human rights in healthcare. Chapters 00:00 Introduction and Liz Parrish's Background 02:49 Liz Parrish's First Human Gene Therapy Experience 03:39 Parenting a Child with Type 1 Diabetes 05:23 Children's Hospitals and Medical Challenges 07:10 The Cost and Accessibility of Life-Saving Treatments 08:08 Hope and Grief in Medical Innovation 10:10 Realization of Unconventional Approaches 11:54 Treating Biological Aging and Childhood Diseases 13:35 Criticism of Incremental Medical Progress 15:27 Resistance to Technological Change in Medicine 16:57 The Potential of Gene Therapy for Humanity 18:59 Biohacking and Scientific Rigor 21:02 The Future of Humanity Without Aging 23:12 The Day of Her Gene Therapy Treatment 25:48 Experiences During the Treatment Process 27:23 What Was Entering Her Body 29:45 Different Gene Therapies Used 30:40 Addressing Critics and Scientific Rigor 33:41 Overcoming Media and Regulatory Challenges 37:26 Debunking Cancer and Safety Myths 47:25 The Science of Telomerase and Cancer Risks 51:21 Gene Therapy Delivery Methods and Toxicity 52:34 Animal Data vs Human Data in Longevity Research 55:11 The Biggest Lie in Longevity Industry 56:32 Misunderstandings About Telomerase Activation 58:35 Regulatory Barriers and Economics in Aging Treatments 01:01:38 Mainstream Pharma's Skepticism Toward Aging as an Indication 01:06:28 The Urgency of Access to Longevity Treatments 01:10:07 Emotional Impact of Treatment Outcomes 01:14:36 The Future of Humanity and Aging 01:16:14 What Will Kill Us in a World Without Aging 01:20:55 Simulation Theory and Reality 01:23:00 Philosophy, Spirituality, and the Nature of Existence 01:25:02 The Power of Upgrading Our Mindset 01:27:18 Closing Remarks and Future Outlook Get vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

  • S1 · E71
    June 3 · 56 min· Video

    Your Body Is Warning You... Most Men Ignore This Sign

    In this episode, Dr Elliot Justin discusses the fascinating connection between sexual health, cardiovascular health, and why the body often provides early warning signs long before more serious health issues emerge. If you'd like to learn more about FirmTech and the technology discussed in this conversation, you can explore it using the link below. As a listener of Drug Diaries, you'll receive 20% off your purchase using the code DRUGDIARIES. 🔗 Affiliate Link: https://myfirmtech.com/kaushiktrivediq5 A note on transparency: FirmTech sponsored this episode and Drug Diaries may earn a commission if you choose to make a purchase through this link. This comes at no additional cost to you. Importantly, 100% of any commissions earned from this partnership will be donated to Childhood Cancer International (CCI), a global charitable organisation that supports children with cancer and their families in low- and middle-income countries. Thank you for supporting both the podcast and this important cause. Chapters 00:00 Breaking the Silence on Sexual Health 02:26 Understanding the Signals of Erectile Dysfunction 04:42 The Importance of Nocturnal Erections 07:32 The Role of Wearables in Sexual Health 09:51The Psychological Barriers to Discussing Sexual Health 12:33 The Misdiagnosis of Erectile Dysfunction 14:56 The Impact of Aging on Sexual Health 17:16 The Shift in Patient Attitudes 19:39 The Legacy of Sexual Health Advocacy 21:42 The Need for Action in Sexual Health 24:14 Planning for Pleasure in Relationships 32:08 Understanding Erectile Dysfunction: The Physiological and Psychological Factors 39:32 The Role of Technology in Sexual Health 44:25 Real User Stories: Transformative Experiences with the Ring 48:47 Behavior Change and the Importance of Tracking Sexual HealthResources Firm Tech Wearable Devices Childhood Cancer International Elliot Justin's Research on Sexual Health MonitoringGuest links LinkedInTwitterGet vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

  • S1 · E70
    May 21 · 1 hr 9 min· Video

    The Proactive Approach That Keeps Me Young

    At 57, hear how being proactive has allowed me to delay many of the typical signs of aging. This discussion highlights the importance of a healthy lifestyle and an aging mindset to experience aging well. Learn how small, consistent choices can contribute to healthy aging and provide longevity tips for everyone. Explore the science of aging with Dr. Sandra Kaufmann, who breaks down aging into seven biological categories and discusses actionable strategies, supplements, and lifestyle choices to slow or reverse aging processes. Chapters 00:00 Understanding Aging: A New Perspective 02:21 The Disconnect in Medicine: A Personal Journey 05:01 The Science of Aging: Chronological vs Physiological 07:51 Breaking Down Aging: The Kaufman Protocol 10:07 The Seven Tenets of Aging 12:55 The Role of Supplements in Longevity 15:42 Exploring the First Tenet: DNA and Telomeres 18:18 Mitochondrial Health: The Second Tenet 21:57 Pathways of Aging: The Third Tenet 25:47 The Foundations of Longevity: Diet and Exercise 27:46 Personalized Health Protocols: Tailoring to Individual Needs 31:05 Understanding Oxidative Stress and Its Impact 31:17 Glycation: The Hidden Dangers of Sugar 37:52 Debunking Longevity Myths: Hyperbaric Oxygen Therapy 39:49 Metformin: A Double-Edged Sword for Longevity 41:18 The Role of Supplements: Balancing Science and Basics 45:12 Key Overlooked Factors for Longevity 46:01 The Importance of Sleep 48:01 Supplements for Better Sleep 50:09 Democratizing Longevity 51:57 Future Perspectives on Aging 53:23 Defining a Well-Lived Life 54:30 Rapid Fire on Longevity Supplements resources The Kaufman Protocol - https://www.kaufmanprotocol.com Sandra Kaufmann's Website - https://www.kaufmanprotocol.com Metformin - https://en.wikipedia.org/wiki/Metformin Resveratrol and Pterostilbene - https://en.wikipedia.org/wiki/Resveratrol NMN and NR supplements - https://en.wikipedia.org/wiki/Nicotinamide_mono nucleotide Exosome Therapy - https://www.exosome.com Connect with Kaushik Trivedi (Host) - https://www.instagram.com/drugdiaries_/

  • S1 · E69
    May 5 · 2 hr 28 min· Video

    How Close Are We to Reversing Aging? Bill Andrews Interview

    This video takes a thought-provoking journey into the fundamental question of why we age, exploring the intricate mechanisms of human biology. It delves into the concept of "biological age" and even presents a unique perspective on "cancer research" and its potential role in "evolution". The discussion also touches upon personal reflections on "mortality", prompting us to consider how to live longer. Kaushik Trivedi interviews Dr. Bill Andrews, a pioneer in genetics and telomere research, about the science of aging, telomerase, and the obstacles to curing aging. They explore the biological mechanisms behind aging, the history of telomere research, and the societal challenges in achieving longevity breakthroughs. In this in-depth interview, Bill Andrews shares his pioneering work in telomere research, anti-aging therapies, and the future of human longevity. Discover how scientific breakthroughs, strategic funding, and personal discipline are shaping the quest to extend healthy lifespan beyond natural limits. keywords aging, telomeres, telomerase, genetics, longevity, biotech, science of aging, Dr. Bill Andrews, anti-aging research, biotech obstacles telomeres, anti-aging, longevity, scientific research, human lifespan, telomerase, aging therapies, biotech innovation, health optimization, future of medicine Chapters 0:00:00 – 0:01:47 Trailer 0:01:47 – 0:03:27 Introduction 0:03:27 – 0:04:32 Why Bill is doing this interview 0:04:32 – 0:23:25 Bill’s background 0:23:25 – 0:28:40 Telomere Biology and Aging 0:28:40 – 0:30:20 Telomerase does not cause cancer 0:30:20 – 0:41:05 Evolution of Aging and other diseases 0:41:05 – 0:45:55 Causes of Aging 0:45:55 – 0:47:12 Why cure aging 0:47:12 – 0:54:53 More on Causes of Aging and Evolution 0:54:53 – 1:13:07 Obstacles to Curing Diseases and the Solutions. 1:13:07 – 1:28:30 How Bill Will Cure Aging 1:28:30 – 1:33:24 Bill’s Research at Sierra Sciences Up to Now. 1:33:24 – 1:36:06 More on Telomere Biology and Aging 1:36:06 – 1:41:38 Searching for Nutraceutical Telomerase Inducers 1:41:38 – 1:44:45 Touchstone Essentials and Telo-Vital 1:44:45 – 1:56:08 Telomere Length and Almost All Diseases 1:56:08 – 2:02:02 Should Aging NOT be Cured? 2:02:02 – 2:22:03 Bill’s Personal Longevity Practices 2:22:03 – 2:23:15 Bill’s Prediction of What Life Will be Like in 30 Years. 2:23:15 – 2:26:36 Longevity and Religion Resources The Immortalists (Documentary) Kaushik Trivedi's Website Dr. Bill Andrews' Research Lab Sierra Sciences Betty White Caldwell Esselstyn's book 'The Prevent and Reverse Heart Disease' Touchstone Essentials TeloVital Kaufman Protocols by Dr. Sandra Kaufman Aubrey de Grey's work on aging Guest links Twitter LinkedIn Website If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore. Connect with Kaushik Trivedi (Host) - https://www.instagram.com/drugdiaries_/

  • S1 · E68
    April 24 · 54 min· Video

    Drug Diaries Den | Innovation Meets Clinical Reality

    Our latest segment introduces "Drug Diaries Den," a platform designed for innovators to present scientific ideas, aiming to accelerate **drug development**. Dr. Subhadra David showcases an innovative AI-enabled digital animal replacement technology, addressing the high failure rates in human clinical trials and improving **drug discovery**. This technology leverages **artificial intelligence** and human microphysiological platforms to enhance **clinical research** and advance **innovation in healthcare** by reducing reliance on traditional **animal research**. This episode features a panel discussion on innovative approaches in drug development, focusing on AI-enabled human microphysiological systems as a replacement for animal testing. Experts share insights on scientific validation, translational feasibility, and the future of ethical, faster, and more accurate drug discovery. Chapters 00:00 Introduction to Drug Diaries Den 02:01 Panel Introduction and Expertise 06:04 Presentation of Innovation by Dr. Subhadra Dhavit 16:54 Discussion and Panel Insights 17:20 The Potential of New Approaches in Drug Development 19:18 Challenges in Evaluating New Drug Modalities 20:20 Feedback and Insights on Drug Development Strategies 23:43 Regulatory Considerations and Validation in Drug Development 28:16 Exploring the Limits of New Technologies 31:30 Evaluating the Platform from a Venture Perspective 35:11 Commercial Opportunities and Challenges in Drug Development 39:55 Assessing Innovation in Biotechnology 44:29 Final Thoughts and Reflections on the Discussion Eesources Transcel Biologics American Association for Precision Medicine Genentech Roche Rutgers University Wise Capitals If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore. Connect with Kaushik Trivedi (Host) - https://www.instagram.com/drugdiaries_/ S. Dravida - https://www.linkedin.com/in/s-dravida-she-her-65011611/ Debraj Dasgupta - https://www.linkedin.com/in/debrajdasgupta/ Paul Agapow - https://www.linkedin.com/in/paul-agapow/ Sadanand Vadola - https://www.linkedin.com/in/sadanand-vodala-305b022a/ Dr. Prasun Mishra - https://www.linkedin.com/in/prasunjmishra/

  • S1 · E67
    April 24 · 1 hr 17 min· Video

    Healthcare's Biggest Problem Isn't Technology, It's This..

    Despite advancements in healthcare technology, the patient care experience often feels fragmented. This video highlights the disconnect between sophisticated medical innovations, like artificial intelligence for early disease detection, and the actual human connection patients receive. We explore how even with cutting-edge technology, the healthcare industry struggles to provide a truly integrated and empathetic experience for individuals. Dr. Fatih Mehmet GUL shares insights on the evolution of healthcare, digital transformation, connected care, AI, and future trends. Discover how technology, human touch, and system re-engineering can create healthier communities and improve patient outcomes. Chapters 00:00 The State of Healthcare Innovation 02:49 Defining Moments in Healthcare Leadership 05:44 Integrating Technology with Human Empathy 08:23 The Importance of Connected Care 11:21 Transforming Patient Experience 14:10 The Role of Caregivers in Healthcare 16:59 Re-engineering Healthcare Systems 20:11 The Next Generation of Patients 23:07 The Need for Continuous Patient Engagement 25:54 The Crisis of Healthcare Professionals 28:52 The Coexistence of Technology and Humanity 31:45 Rethinking Healthcare Operations 34:35 The True State of Global Healthcare 39:40 Navigating Healthcare Complexity 43:46 The Role of AI in Healthcare 48:38 AI Successes and Failures 53:25 Patient Experience and Technology 57:45 Challenges in Healthcare Innovation 01:01:58 Global Influences on Healthcare 01:03:13 Future of Healthcare: A Decade Ahead 01:07:55 Longevity and Healthy Aging 01:12:02 Myths vs. Realities in Healthcare 01:14:11 Confronting Healthcare Realities Resources Connected Care Framework AI Governance in Healthcare If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore. Connect with Kaushik Trivedi: Instagram: https://www.instagram.com/drugdiaries_/

  • S1 · E66
    April 24 · 1 hr· Video

    Your Body Shape Doesn't Define Your Worth

    Is obesity a failure of the individual, or a chronic disease shaped by biology, environment, psychology, and systems? This video explores the complexities of obesity treatment, questioning whether it's an individual's fault or a deeper issue. We discuss how lifestyle medicine and understanding insulin resistance are crucial in effective weight management, moving beyond simple solutions. Kaushik Trivedi hosts Sarah Le Brocq to explore the complex realities of obesity, emphasizing lived experience, science, policy, and systemic change. This conversation challenges oversimplified narratives and advocates for compassionate, evidence-based approaches. Obesity, lived experience, healthcare policy, stigma, treatment, systemic change, mental health, medical innovation, advocacy Chapters 00:00 Rethinking Obesity: A New Narrative 01:52 The Human Experience Behind Obesity 11:17 The Complexity of Obesity: Beyond Willpower 17:45 Stigma and Its Impact on Healthcare 22:27 From Personal Journey to Advocacy 25:44 Integrating Lived Experience in Healthcare Advocacy 27:12 Authenticity in Storytelling 28:45 The Bigger Picture in Advocacy 30:25 The Importance of Patient Voices 32:08 Current Trends in Obesity Care 37:44 Access to Innovative Treatments 38:39 Defining Obesity: A Complex Issue 43:24 Challenges in NHS Prescriptions 45:51 The Role of Pharmaceutical Companies 49:07 Envisioning Future Obesity Care 51:28 Personal Reflections on Resilience 55:04 A Message to Those Living with Obesity If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore. Connect with Kaushik Trivedi: Instagram: https://www.instagram.com/drugdiaries_/

  • S1 · E65
    April 24 · 55 min· Video

    Your Healthspan Is Already Decided, And It’s Not in Your Blood Tests

    keywords healthspan, functionality, aging, wellness, resilience, health metrics, functional capacity, dual task training, empowerment, social health takeaways Health span is determined by how we function, not just lab results. Functional blindness refers to being unaware of our physical capabilities. Our weakest link in health can determine our overall health span. Fitness does not equate to resilience; balance is crucial. Functional metrics can predict health span better than disease indicators. The five domains of function are strength, cardiovascular health, mobility, structure, and cognition. Simple tests can assess functional capacity at home. Dual task training enhances brain function and resilience. Awareness of functional capacity empowers individuals to take action. Social engagement can enhance the experience of improving health span. summary In this conversation, Prof. Scott Fulton discusses the concept of healthspan, emphasizing the importance of functionality over traditional health metrics. He introduces the idea of functional blindness, where individuals are unaware of their physical capabilities, and explains how our weakest link can determine overall health. Fulton outlines the five domains of function—strength, cardiovascular health, mobility, structure, and cognition—and provides practical assessments for individuals to gauge their functional capacity. He highlights the significance of dual task training for brain health and the empowering nature of awareness in shaping one's aging experience. The discussion concludes with a focus on the social aspects of functionality and the importance of community in enhancing healthspan. Chapters 00:00 Understanding Health Span vs. Disease 03:12 The Concept of Functional Blindness 06:19 The Weakest Link in Health Span 09:20 Function as a Predictor of Health Span 14:15 The Five Domains of Function 18:57 Understanding VO2 Max 20:10 Simple Tests for Functional Assessment 25:23 Empowering Daily Life Choices 26:41 The Blue Zones and Functional Living 28:28 Defining Functional Age 28:52 Understanding Functional Ability Across Ages 31:17 The Shift from Reactive to Preventive Medicine 34:30 The Importance of Dual Task Training 43:54 Discovering Functional Blind Spots 47:54 Empowerment Through Awareness and Agency 51:27 The Social Aspect of Function and Healthspan If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore. Connect with Kaushik Trivedi: Instagram: https://www.instagram.com/drugdiaries_/

  • S1 · E64
    March 24 · 1 hr 2 min· Video

    Can We Really Extend Healthspan? Only If You're Rich

    Our latest discussion explores the universal desire for a healthy, long life, emphasizing that aging is a primary driver of disease. We consider various approaches to healthy ageing and the pursuit of a longer healthspan. While true solutions for how to live longer currently favor the wealthy, understanding aging biology and metabolic health are crucial for disease prevention. This episode prompts us to rethink access to longevity solutions for everyone. In this conversation, Kaushik Trivedi and Dylan Livingston explore the implications of aging as a treatable condition rather than an inevitable decline. They discuss the role of policy in shaping longevity research, the need for societal acceptance of aging interventions, and the potential economic benefits of extending healthy lifespans. The conversation also touches on the risks associated with longevity breakthroughs and the importance of making these advancements accessible to all. Ultimately, they emphasize the need for a shift in healthcare from reactive to proactive measures, highlighting the societal changes that could arise from longer, healthier lives. Chapters 00:00 The Uncomfortable Truth About Aging 01:26 The Disruption of Aging Policy 03:11 Dylan's Journey into Longevity Advocacy 08:44 Bridging Science and Policy 10:24 The Need for Diverse Voices in Longevity 12:12 Inspiration from Pioneers in the Field 13:04 The Unconventional Path to Advocacy 15:16 Curiosity Over Skepticism in Policy Discussions 19:18 Bipartisan Support for Longevity Initiatives 24:34 Aging 1.0 vs. Aging 2.0 27:07 The Economic Impact of Healthy Aging 30:11 Making Longevity Accessible to All 32:41 The Role of Government in Longevity Drug Accessibility 34:08 Awareness and Misconceptions in Longevity 36:51 Realism vs. Hype in Longevity Innovations 39:25 Mainstreaming Longevity Medicine 43:42 Government's Role in Longevity Interventions 47:35 Societal Changes with Extended Lifespan 53:09 The Future of Work and Leisure in an AI-Driven World 54:07 Potential Risks of Extended Lifespan 56:21 Hope and Challenges in Longevity Advocacy If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore. Connect with Kaushik Trivedi: Instagram: https://www.instagram.com/drugdiaries_/

  • S1 · E63
    March 24 · 38 min· Video

    Reinvention After Corporate: The Untold Reality

    In this conversation, Kaushik Trivedi and Debraj Dasgupta explore the evolving landscape of careers, leadership, and the importance of human connection in a rapidly changing world. They discuss the challenges of digital transformation, the need for a cultural shift in organizations, and the significance of building communities. Debraj shares his personal journey from corporate life to entrepreneurship, emphasizing the importance of redefining success and fulfillment. The conversation highlights the necessity of human relationships in an age dominated by technology and AI, and the responsibility of leaders to invest in the next generation. Takeaways Most careers stall rather than end, leading to a crisis of meaning. Digital transformation fails when organizational culture does not evolve. Networking should focus on building trust rather than just contacts. Success and fulfillment can diverge in one's career journey. Reinvention requires courage and a willingness to embrace uncertainty. Human connection becomes more valuable as technology advances. The future of work will involve collaboration between humans and AI. Companies must adapt to retain talent by fostering a supportive culture. Building communities is essential in the digital age. Leaders have a responsibility to mentor and support the next generation. Chapters 00:00 The Crossroads of Career and Meaning 02:13 Navigating Career Phases and Personal Growth 04:55 Redefining Success and Fulfillment 07:35 The Courage to Reinvent 09:58 Building Digital Culture vs. Digital Projects 12:23 The Myths of Digital Transformation 14:53 Future-Ready Talent and Retention Challenges 19:43 Navigating the Future of Work 22:03 Identity and Career Transitions 24:19 The Art of Networking 26:53 Building Communities in a Digital Age 29:12 AI's Role in Leadership 31:30 The Leadership Vacuum and Next Generation 32:57 The Responsibility of Experienced Leaders 34:28 The Importance of Human Connection If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore. Connect with Kaushik Trivedi: Instagram: https://www.instagram.com/drugdiaries_/

Showing 1–20 of 22 episodes